The mRNA Expression and Circulating Levels of Visfatin and Their Correlation With Coronary Artery Disease Severity and 25-Hydroxyvitamin D

Hormone and Metabolic Research - Germany
doi 10.1055/s-0035-1564133
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Georg Thieme Verlag KG

Related search

Evaluation of the Correlation of 25-Hydroxyvitamin-D Serum Levels With Allergic Rhinitis

ENT Updates
2015English

Circulating Serum 25-Hydroxyvitamin D Levels and Bone Mineral Density: Mendelian Randomization Study

Journal of Bone and Mineral Research
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2018English

Inflammation Modifies the Association of Obesity With Circulating 25-Hydroxyvitamin D Levels in Cancer Survivors

Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2017English

A Cross-Sectional Study of the Association Between Circulating 25-Hydroxyvitamin D Levels and Predicted Operative Mortality of Patients With Cardiovascular Disease

Journal of Nutritional Science and Vitaminology
MedicineNutritionDietetics
2012English

Aqueous Humor and Serum 25-Hydroxyvitamin D Levels in Patients With Cataracts

BMC Ophthalmology
MedicineOphthalmology
2020English

Correlation Between Severity of Coronary Artery Disease and Severity of Peripheral Artery Disease, a Detail Analytical Study From Eastern India

Journal of Cardiology & Cardiovascular Therapy
2018English

Relationship Between microRNA-206 Plasma Levels With the Severity of Coronary Artery Conflicts in Patients With Coronary Artery Disease

Bratislava Medical Journal
2019English

Circulating microRNA-378 Levels Serve as a Novel Biomarker for Assessing Severity of Coronary Stenosis in Patients With Coronary Artery Disease

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2019English

Serum Visfatin Levels in Acromegaly: Correlation With Disease Activity and Metabolic Alterations

Growth Hormone and IGF Research
EndocrinologyMetabolismDiabetes
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy